Stanford Study Uncovers Surprising Twist in Ketamine’s Effect on Depression

Studies with favorable results for antidepressant use (i.e., reduced suicide risk or no effect) are more often published in psychiatric journals than studies with unfavorable results (i.e., increased suicide risk), according to a systematic review published in Journal of Clinical Epidemiology.

People with depression can't access potentially life-changing treatment with ketamine because current systems prioritize profits, not patients & payers. New study reveals the systemic barriers that prevent the utilization of existing, low-cost drugs.

Pupil response may shed light on who responds best to transcranial magnetic stimulation for depression